{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:25:36Z","timestamp":1789079136742,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10147-024-02576-2","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:04:47Z","timestamp":1719911087000},"page":"1055-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pancreatic cancer and sarcopenia: a narrative review of the current status"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-9615","authenticated-orcid":false,"given":"Mariko","family":"Tsukagoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"2576_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE et al (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"2576_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.annonc.2021.01.006","volume":"32","author":"G Carioli","year":"2021","unstructured":"Carioli G, Malvezzi M, Bertuccio P et al (2021) European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol 32:478\u2013487","journal-title":"Ann Oncol"},{"key":"2576_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1148\/rg.2020190184","volume":"40","author":"K Schawkat","year":"2020","unstructured":"Schawkat K, Manning MA, Glickman JN et al (2020) Pancreatic ductal adenocarcinoma and its variants: pearls and perils. Radiographics 40:1219\u20131239","journal-title":"Radiographics"},{"key":"2576_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ags3.12320","volume":"4","author":"H Yamaue","year":"2020","unstructured":"Yamaue H (2020) History of pancreatic surgery in Japan: respect to the Japanese pioneers of pancreatic surgery. Ann Gastroenterol Surg 4:118\u2013125","journal-title":"Ann Gastroenterol Surg"},{"key":"2576_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ags3.12662","volume":"7","author":"Y Kajiwara","year":"2023","unstructured":"Kajiwara Y, Takahashi A, Ueno H et al (2023) Annual report on National Clinical Database 2020 for gastroenterological surgery in Japan. Ann Gastroenterol Surg 7:367\u2013406","journal-title":"Ann Gastroenterol Surg"},{"key":"2576_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249\u2013256","journal-title":"J Am Med Dir Assoc"},{"key":"2576_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331","journal-title":"Age Ageing"},{"key":"2576_CR8","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/jpen.2415","volume":"46","author":"A Surov","year":"2022","unstructured":"Surov A, Wienke A (2022) Prevalence of sarcopenia in patients with solid tumors: a meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr 46:1761\u20131768","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2576_CR9","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.acra.2022.10.025","volume":"30","author":"M Thormann","year":"2023","unstructured":"Thormann M, Hinnerichs M, Barajas Ordonez F et al (2023) Sarcopenia is an independent prognostic factor in patients with pancreatic cancer - a meta-analysis. Acad Radiol 30:1552\u20131561","journal-title":"Acad Radiol"},{"key":"2576_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.amjsurg.2022.03.025","volume":"224","author":"AN Gunesch","year":"2022","unstructured":"Gunesch AN, Sutton TL, Krasnow SM et al (2022) Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer. Am J Surg 224:742\u2013746","journal-title":"Am J Surg"},{"key":"2576_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291185","volume":"19","author":"E Khristenko","year":"2024","unstructured":"Khristenko E, Sinitsyn V, Rieden T et al (2024) CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer. PLoS ONE 19:e0291185","journal-title":"PLoS ONE"},{"key":"2576_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109834","volume":"142","author":"TH Hsu","year":"2021","unstructured":"Hsu TH, Schawkat K, Berkowitz SJ et al (2021) Artificial intelligence to assess body composition on routine abdominal CT scans and predict mortality in pancreatic cancer- A recipe for your local application. Eur J Radiol 142:109834","journal-title":"Eur J Radiol"},{"key":"2576_CR13","doi-asserted-by":"publisher","first-page":"5546030","DOI":"10.1155\/2021\/5546030","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu J, Li F et al (2021) Contrast-enhanced computed tomography does not provide more information about sarcopenia than unenhanced computed tomography in patients with pancreatic cancer. Contrast Media Mol Imaging 2021:5546030","journal-title":"Contrast Media Mol Imaging"},{"key":"2576_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","volume":"31","author":"CM Prado","year":"2012","unstructured":"Prado CM, Wells JC, Smith SR et al (2012) Sarcopenic obesity: a Critical appraisal of the current evidence. Clin Nutr 31:583\u2013601","journal-title":"Clin Nutr"},{"key":"2576_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom TK, Miller DK, Simonsick EM et al (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7:28\u201336","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2576_CR16","doi-asserted-by":"publisher","first-page":"20690","DOI":"10.1002\/cam4.6599","volume":"12","author":"DL Hess","year":"2023","unstructured":"Hess DL, Harmon C, Bhatia S et al (2023) SARC-F as a screening tool to detect computed tomography-based sarcopenia and myosteatosis among older adults with cancer. Cancer Med 12:20690\u201320698","journal-title":"Cancer Med"},{"key":"2576_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2020.110957","volume":"79\u201380","author":"K Miyoshi","year":"2020","unstructured":"Miyoshi K, Shimoda M, Udo R et al (2020) Urinary titin N-terminal fragment concentration is an indicator of preoperative sarcopenia and nutritional status in patients with gastrointestinal tract and hepatobiliary pancreatic malignancies. Nutrition 79\u201380:110957","journal-title":"Nutrition"},{"key":"2576_CR18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.clnu.2019.07.027","volume":"39","author":"Y Tabara","year":"2020","unstructured":"Tabara Y, Kohara K, Okada Y et al (2020) Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study. Clin Nutr 39:1857\u20131862","journal-title":"Clin Nutr"},{"key":"2576_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/ags3.12671","volume":"7","author":"M Tsukagoshi","year":"2023","unstructured":"Tsukagoshi M, Watanabe A, Araki K et al (2023) Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer. Ann Gastroenterol Surg 7:784\u2013792","journal-title":"Ann Gastroenterol Surg"},{"key":"2576_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1055\/a-1959-2894","volume":"61","author":"J Mandl","year":"2023","unstructured":"Mandl J, Baumer S, Holtzem B et al (2023) Sarcopenia in patients with pancreatic cancer, an independant prognostic factor. Z Gastroenterol 61:1365\u20131370","journal-title":"Z Gastroenterol"},{"key":"2576_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/00369330231187655","volume":"68","author":"H Gan","year":"2023","unstructured":"Gan H, Lan J, Bei H et al (2023) The impact of sarcopenia on prognosis of patients with pancreatic cancer: a systematic review and meta-analysis. Scott Med J 68:133\u2013148","journal-title":"Scott Med J"},{"key":"2576_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215915","volume":"14","author":"ES Gruber","year":"2019","unstructured":"Gruber ES, Jomrich G, Tamandl D et al (2019) Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS One 14:e0215915","journal-title":"PLoS One"},{"key":"2576_CR23","first-page":"3670","volume":"25","author":"B Pessia","year":"2021","unstructured":"Pessia B, Giuliani A, Romano L et al (2021) The role of sarcopenia in the pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci 25:3670\u20133678","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2576_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111660","volume":"99\u2013100","author":"Y Aoki","year":"2022","unstructured":"Aoki Y, Furukawa K, Suzuki D et al (2022) Influence of sarcopenia as defined by EWGSOP2 on complications after pancreaticoduodenectomy and on the prognosis of pancreatic head cancer: a prospective cohort study. Nutrition 99\u2013100:111660","journal-title":"Nutrition"},{"key":"2576_CR25","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.hpb.2020.04.004","volume":"22","author":"Y Ryu","year":"2020","unstructured":"Ryu Y, Shin SH, Kim JH et al (2020) The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer. HPB (Oxford) 22:1782\u20131792","journal-title":"HPB (Oxford)"},{"key":"2576_CR26","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.1002\/cam4.5779","volume":"12","author":"XD Shen","year":"2023","unstructured":"Shen XD, Wang X, Zheng ZJ et al (2023) The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: a retrospective study based on a large population. Cancer Med 12:10438\u201310448","journal-title":"Cancer Med"},{"key":"2576_CR27","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s00330-020-07294-7","volume":"31","author":"YC Peng","year":"2021","unstructured":"Peng YC, Wu CH, Tien YW et al (2021) Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy. Eur Radiol 31:2472\u20132481","journal-title":"Eur Radiol"},{"key":"2576_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12957-024-03310-y","volume":"22","author":"C Liu","year":"2024","unstructured":"Liu C, An L, Zhang S et al (2024) Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis. World J Surg Oncol 22:38","journal-title":"World J Surg Oncol"},{"key":"2576_CR29","first-page":"45","volume":"94","author":"V La Vaccara","year":"2023","unstructured":"La Vaccara V, Cascone C, Coppola A et al (2023) Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer. Ann Ital Chir 94:45\u201351","journal-title":"Ann Ital Chir"},{"key":"2576_CR30","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1245\/s10434-023-13569-2","volume":"30","author":"S Masuda","year":"2023","unstructured":"Masuda S, Yamakawa K, Masuda A et al (2023) Association of sarcopenia with a poor prognosis and decreased tumor-infiltrating CD8-positive T cells in pancreatic ductal adenocarcinoma: A retrospective analysis. Ann Surg Oncol 30:5776\u20135787","journal-title":"Ann Surg Oncol"},{"key":"2576_CR31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1245\/s10434-011-1594-6","volume":"18","author":"DY Greenblatt","year":"2011","unstructured":"Greenblatt DY, Kelly KJ, Rajamanickam V et al (2011) Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 18:2126\u20132135","journal-title":"Ann Surg Oncol"},{"key":"2576_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.pan.2023.05.006","volume":"23","author":"D Tazeoglu","year":"2023","unstructured":"Tazeoglu D, Benli S, Colak T et al (2023) Comparative analysis of the sarcopenia and HALP score on postoperative outcomes in pancreatic cancer patients after pancreatoduodenectomy. Pancreatology 23:530\u2013536","journal-title":"Pancreatology"},{"key":"2576_CR33","doi-asserted-by":"publisher","first-page":"E433","DOI":"10.1111\/ans.15379","volume":"89","author":"R Shintakuya","year":"2019","unstructured":"Shintakuya R, Sasaki M, Nakamitsu A et al (2019) Sarcopenia is an independent predictor of delayed gastric emptying following pancreaticoduodenectomy: a retrospective study. ANZ J Surg 89:E433\u2013E437","journal-title":"ANZ J Surg"},{"key":"2576_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.gastrohep.2020.01.001","volume":"43","author":"RA Latorre Fragua","year":"2020","unstructured":"Latorre Fragua RA, Manuel V\u00e1zquez A, Ramiro P\u00e9rez C et al (2020) Influence of sarcopenia in major pancreatic surgery. A systematic review of the literature. Gastroenterol Hepatol 43:142\u2013154","journal-title":"Gastroenterol Hepatol"},{"key":"2576_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.hpb.2019.05.018","volume":"21","author":"J Bundred","year":"2019","unstructured":"Bundred J, Kamarajah SK, Roberts KJ (2019) Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB (Oxford) 21:1603\u20131612","journal-title":"HPB (Oxford)"},{"key":"2576_CR36","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.3390\/cancers13164105","volume":"13","author":"M Tsukagoshi","year":"2021","unstructured":"Tsukagoshi M, Harimoto N, Araki K et al (2021) Skeletal muscle loss and octogenarian status are associated with S-1 adjuvant therapy discontinuation and poor prognosis after pancreatectomy. Cancers (Basel) 13:4105","journal-title":"Cancers (Basel)"},{"key":"2576_CR37","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/cam4.5155","volume":"12","author":"Q Jin","year":"2023","unstructured":"Jin Q, Ren Q, Chang X et al (2023) Pylorus-preserving versus Pylorus-resecting: impact on dynamic changes of nutrition and body composition in pancreatic cancer patients before and after pancreatoduodenectomy. Cancer Med 12:2713\u20132721","journal-title":"Cancer Med"},{"key":"2576_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12957-020-01981-x","volume":"18","author":"T Sakamoto","year":"2020","unstructured":"Sakamoto T, Yagyu T, Uchinaka E et al (2020) Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: a retrospective study. World J Surg Oncol 18:221","journal-title":"World J Surg Oncol"},{"key":"2576_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111826","volume":"103\u2013104","author":"N Nasu","year":"2022","unstructured":"Nasu N, Yasui-Yamada S, Kagiya N et al (2022) Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancers. Nutrition 103\u2013104:111826","journal-title":"Nutrition"},{"key":"2576_CR40","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3348\/kjr.2022.0277","volume":"23","author":"DW Kim","year":"2022","unstructured":"Kim DW, Ahn H, Kim KW et al (2022) Prognostic value of sarcopenia and myosteatosis in patients with resectable pancreatic ductal adenocarcinoma. Korean J Radiol 23:1055\u20131066","journal-title":"Korean J Radiol"},{"key":"2576_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H et al (2019) Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol 49:190\u2013194","journal-title":"Jpn J Clin Oncol"},{"key":"2576_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/jjco\/hyaa247","volume":"51","author":"T Takeda","year":"2021","unstructured":"Takeda T, Sasaki T, Mie T et al (2021) The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer. Jpn J Clin Oncol 51:604\u2013611","journal-title":"Jpn J Clin Oncol"},{"key":"2576_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pan.2022.11.010","volume":"23","author":"M Shimura","year":"2023","unstructured":"Shimura M, Mizuma M, Motoi F et al (2023) Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. Pancreatology 23:65\u201372","journal-title":"Pancreatology"},{"key":"2576_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.gassur.2023.12.022","volume":"28","author":"DPS Sohal","year":"2024","unstructured":"Sohal DPS, Boutin RD, Lenchik L et al (2024) Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505. J Gastrointest Surg 28:232\u2013235","journal-title":"J Gastrointest Surg"},{"key":"2576_CR45","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691\u20131703","journal-title":"N Engl J Med"},{"key":"2576_CR46","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.0900-22","volume":"62","author":"A Ishizaki","year":"2023","unstructured":"Ishizaki A, Okuwaki K, Kida M et al (2023) Implication of skeletal muscle loss in the prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy. Intern Med 62:2783\u20132793","journal-title":"Intern Med"},{"key":"2576_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pan.2021.12.013","volume":"22","author":"T Emori","year":"2022","unstructured":"Emori T, Itonaga M, Ashida R et al (2022) Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy. Pancreatology 22:277\u2013285","journal-title":"Pancreatology"},{"key":"2576_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MPA.0000000000001985","volume":"51","author":"H Asama","year":"2022","unstructured":"Asama H, Ueno M, Kobayashi S et al (2022) Sarcopenia: prognostic value for unresectable pancreatic ductal adenocarcinoma patients treated with gemcitabine plus nab-paclitaxel. Pancreas 51:148\u2013152","journal-title":"Pancreas"},{"key":"2576_CR49","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10147-021-01912-0","volume":"26","author":"T Takeda","year":"2021","unstructured":"Takeda T, Sasaki T, Suzumori C et al (2021) The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. Int J Clin Oncol 26:1293\u20131303","journal-title":"Int J Clin Oncol"},{"key":"2576_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1590\/s0004-2803.202000000-52","volume":"57","author":"APN Barr\u00c8re","year":"2020","unstructured":"Barr\u00c8re APN, Piovacari SMF, Us\u00d3n Junior PLS et al (2020) Body composition impact on survival and toxicity of treatment in pancreatic cancer: cross-sectional pilot study. Arq Gastroenterol 57:278\u2013282","journal-title":"Arq Gastroenterol"},{"key":"2576_CR51","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1017\/S0007114520003463","volume":"125","author":"S Uemura","year":"2021","unstructured":"Uemura S, Iwashita T, Ichikawa H et al (2021) The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during folfirinox therapy. Br J Nutr 125:1140\u20131147","journal-title":"Br J Nutr"},{"key":"2576_CR52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MPA.0000000000001796","volume":"50","author":"N Williet","year":"2021","unstructured":"Williet N, Fovet M, Maoui K et al (2021) A low total psoas muscle area index is a strong prognostic factor in metastatic pancreatic cancer. Pancreas 50:579\u2013586","journal-title":"Pancreas"},{"key":"2576_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-020-07753-w","volume":"21","author":"IH Kim","year":"2021","unstructured":"Kim IH, Choi MH, Lee IS et al (2021) Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer 21:77","journal-title":"BMC Cancer"},{"key":"2576_CR54","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.pan.2021.03.002","volume":"21","author":"H Sato","year":"2021","unstructured":"Sato H, Goto T, Hayashi A et al (2021) Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: survival analysis using the Weibull exponential distribution model. Pancreatology 21:892\u2013902","journal-title":"Pancreatology"},{"key":"2576_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102219","volume":"9","author":"J Keyl","year":"2024","unstructured":"Keyl J, Bucher A, Jungmann F et al (2024) Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study. ESMO Open 9:102219","journal-title":"ESMO Open"},{"key":"2576_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/SPC.0000000000000455","volume":"13","author":"D Basile","year":"2019","unstructured":"Basile D, Corvaja C, Caccialanza R et al (2019) Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients. Curr Opin Support Palliat Care 13:279\u2013285","journal-title":"Curr Opin Support Palliat Care"},{"key":"2576_CR57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0300891620937795","volume":"107","author":"WK Cho","year":"2021","unstructured":"Cho WK, Yu JI, Park HC et al (2021) Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy. Tumori 107:247\u2013253","journal-title":"Tumori"},{"key":"2576_CR58","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pan.2019.07.039","volume":"19","author":"OM Griffin","year":"2019","unstructured":"Griffin OM, Duggan SN, Ryan R et al (2019) Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. Pancreatology 19:850\u2013857","journal-title":"Pancreatology"},{"key":"2576_CR59","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1007\/s00330-021-07899-6","volume":"31","author":"E Salinas-Miranda","year":"2021","unstructured":"Salinas-Miranda E, Deniffel D, Dong X et al (2021) Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer. Eur Radiol 31:8662\u20138670","journal-title":"Eur Radiol"},{"key":"2576_CR60","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/MPA.0000000000002013","volume":"51","author":"K Iede","year":"2022","unstructured":"Iede K, Yamada T, Koh M et al (2022) Baseline factors predictive of the receipt of second-line chemotherapy after nab-paclitaxel plus gemcitabine for patients with advanced pancreatic cancer. Pancreas 51:278\u2013281","journal-title":"Pancreas"},{"key":"2576_CR61","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s12029-021-00672-4","volume":"52","author":"M Jalal","year":"2021","unstructured":"Jalal M, Campbell JA, Wadsley J et al (2021) Computed tomographic sarcopenia in pancreatic cancer: further utilization to plan patient management. J Gastrointest Cancer 52:1183\u20131187","journal-title":"J Gastrointest Cancer"},{"key":"2576_CR62","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1002\/cam4.3964","volume":"10","author":"O Nakano","year":"2021","unstructured":"Nakano O, Kawai H, Kobayashi T et al (2021) Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer. Cancer Med 10:4291\u20134301","journal-title":"Cancer Med"},{"key":"2576_CR63","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2174\/1573405618666220303105410","volume":"18","author":"B \u00d6zkul","year":"2022","unstructured":"\u00d6zkul B, \u00d6zkul \u00d6, Bilir C (2022) Predicting the overall survival in patients with advanced pancreatic cancer by calculating L3 skeletal muscle index derived from CT. Curr Med Imaging 18:1079\u20131085","journal-title":"Curr Med Imaging"},{"key":"2576_CR64","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1245\/s10434-019-07707-y","volume":"26","author":"K Akashi","year":"2019","unstructured":"Akashi K, Yokoyama Y, Mizuno T et al (2019) Association between preoperative muscle mass and intraoperative bacterial translocation in patients undergoing hepatectomy, pancreatoduodenectomy, and esophagectomy. Ann Surg Oncol 26:4805\u20134813","journal-title":"Ann Surg Oncol"},{"key":"2576_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","volume":"49","author":"C Nelke","year":"2019","unstructured":"Nelke C, Dziewas R, Minnerup J et al (2019) Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 49:381\u2013388","journal-title":"EBioMedicine"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02576-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T07:51:25Z","timestamp":1732348285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02576-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02576-2","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The authors report no proprietary or commercial interests in any product mentioned or concept discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not require ethical approval because it was a review of published articles and did not directly involve human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}